Posts Tagged ‘Reuters’
Tuesday, June 28th, 2011

Higher prices boost McDonald’s April sales
by Lisa Baertlein and Jessica Wohl
For more information go to www.reuters.com.
The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities identified and described in this article do not represent all of the securities purchased or recommended for our clients. It should not be assumed that investing in these securities was or will be profitable. A list of all recommendations made by Smead Capital Management with in the past twelve month period is available upon request.
Tags: Bill Smead, Jessica Wohl, Lisa Baertlein, McDonalds, Reuters
Posted in Press | No Comments »
Tuesday, June 28th, 2011

Walgreen balks, walks away from Express Scripts
by Jessica Wohl and Phil Wahba
For more information go to www.reuters.com.
The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities identified and described in this article do not represent all of the securities purchased or recommended for our clients. It should not be assumed that investing in these securities was or will be profitable. A list of all recommendations made by Smead Capital Management with in the past twelve month period is available upon request.
Tags: Bill Smead, Jessica Wohl, Phil Wahba, Reuters, Walgreens
Posted in Press | No Comments »
Friday, October 8th, 2010

Accenture raises profit outlook, lifts dividend
by Ritsuko Ando
For more information go to www.reuters.com.
The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities identified and described in this article do not represent all of the securities purchased or recommended for our clients. It should not be assumed that investing in these securities was or will be profitable. A list of all recommendations made by Smead Capital Management with in the past twelve month period is available upon request.
Tags: Accenture, Bill Smead, Reuters, Ritsuko Ando
Posted in Press | No Comments »
Friday, June 25th, 2010

Walgreen profit weaker than expected
by Ben Klayman
For more information go to www.reuters.com.
The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities identified and described in this article do not represent all of the securities purchased or recommended for our clients. It should not be assumed that investing in these securities was or will be profitable. A list of all recommendations made by Smead Capital Management with in the past twelve month period is available upon request.
Tags: ben klayman, Bill Smead, Reuters, Walgreens
Posted in Press | No Comments »
Friday, April 16th, 2010

Cheap health stocks seen outpacing other sectors
by Lewis Krauskopf
For more information go to www.reuters.com.
The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities identified and described in this article do not represent all of the securities purchased or recommended for our clients. It should not be assumed that investing in these securities was or will be profitable. A list of all recommendations made by Smead Capital Management with in the past twelve month period is available upon request.
Tags: Bill Smead, Lewis Krauskopf, Pharmaceuticals, Reuters
Posted in Press | No Comments »